Kymera Investor Day Presentation Deck

What We Hope You Will Take from Today • Targeted Protein Degradation is positioned to transform drug development ● landscape Kymera is a medicine focused company with recognized leadership in TPD • We employ a novel and differentiated scientific strategy and approach around target selection, drug development and platform investments We are committed to innovation, execution and to the pursuit of real step change in treatment paradigms There is much we have accomplished since our founding, but even more we expect to deliver in 2022 and beyond We have a very ambitious but achievable vision for the company KYMERA ©2021 KYMERA THERAPEUTICS, INC. KYMERA R&D DAY - December 16th, 2021 PAGE 104

View entire presentation